scispace - formally typeset
J

Joseph S. Bresee

Researcher at Centers for Disease Control and Prevention

Publications -  261
Citations -  35039

Joseph S. Bresee is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Rotavirus & Vaccination. The author has an hindex of 78, co-authored 255 publications receiving 32225 citations. Previous affiliations of Joseph S. Bresee include National Center for Immunization and Respiratory Diseases.

Papers
More filters
Journal ArticleDOI

Overview of Influenza Vaccines in Children

TL;DR: The evidence base for pediatric influenza vaccination is summarized, the challenges and limitations of protecting this population with currently available vaccines are described, and the estimates of vaccine effectiveness vary widely by year, age group, and vaccine studied.
Journal ArticleDOI

Outbreak of antiviral drug-resistant influenza a in long-term care facility, Illinois, USA, 2008

TL;DR: An outbreak of oseltamivir-resistant influenza A (H1N1) occurred in a long-term care facility and the outbreak abated, likely because of infection control measures.
Journal ArticleDOI

Introducing seasonal influenza vaccine in low‐income countries: an adverse events following immunization survey in the Lao People's Democratic Republic

TL;DR: In 2012, Lao PDR introduced seasonal influenza vaccine in pregnant women, persons aged ≥50 years, persons with chronic diseases, and healthcare personnel and adverse events following immunization (AEFI).
Journal ArticleDOI

Association of influenza vaccination during pregnancy with birth outcomes in Nicaragua.

TL;DR: Evidence is found to support an association between influenza vaccination and birth outcomes by trimester of receipt with data from an urban population in Nicaragua.
Journal Article

[Surveillance finding on rotavirus in Changchun children's hospital during July 1998-June 2001].

TL;DR: Rotavirus is the major cause of severe child diarrhea in Changchun city, and developing a rotavirus vaccine for prevention of severe disease and reduction of treatment costs seemed to be necessary.